PTGS2 and neoplasm: The study of HQ in controlling angiogenesis revealed that HQ exerted anti-tumor activity in colon cancer cells via modulation of mTOR and COX-2 signaling, which together reduced VEGF expression to suppress angiogenesis in human CRC cell and tumor xenograft (Auyeung et al., 2016).